EyePoint (EYPT) Change in Acquisitions & Divestments (2010 - 2026)
EyePoint (EYPT) reported Change in Acquisitions & Divestments of $70.0 million for Q1 2026, down 11.64% on a YoY basis from $79.2 million in Q1 2025, and down 6.67% sequentially from $75.0 million in Q4 2025.
EyePoint (EYPT) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
EyePoint (EYPT) has 13 years of Change in Acquisitions & Divestments data on file, last reported at $70.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 11.64% year-over-year to $70.0 million; the trailing twelve-month figure through Mar 2026 stood at $314.5 million (up 30.92% YoY), and the FY2025 full-year result was $323.7 million, up 76.9% from the prior year.
- Change in Acquisitions & Divestments eased to $70.0 million in Q1 2026, from $75.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $103.5 million in Q2 2025 to a low of $3.0 million in Q4 2023.
- A 5-year average of $47.3 million and a median of $44.0 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments slumped 93.62% in 2023 and surged 2183.33% in 2024, its largest moves.
- Tracing EYPT's Change in Acquisitions & Divestments over 5 years: stood at $47.0 million in 2022, then tumbled by 93.62% to $3.0 million in 2023, then surged by 2183.33% to $68.5 million in 2024, then rose by 9.49% to $75.0 million in 2025, then fell by 6.67% to $70.0 million in 2026.
- Business Quant data shows EYPT's Change in Acquisitions & Divestments at $70.0 million in Q1 2026, $75.0 million in Q4 2025, and $66.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | EyePoint | 1.06 Mn | -221.48 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.00 Mn |
| Mar 31, 2026 | 70.00 Mn |
| Dec 31, 2025 | 75.00 Mn |
| Dec 31, 2025 | 75.00 Mn |
| Sep 30, 2025 | 66.00 Mn |
| Sep 30, 2025 | 66.00 Mn |
| Jun 30, 2025 | 103.50 Mn |
| Jun 30, 2025 | 103.50 Mn |
| Mar 31, 2025 | 79.23 Mn |
| Mar 31, 2025 | 79.23 Mn |
| Dec 31, 2024 | 68.50 Mn |
| Dec 31, 2024 | 68.50 Mn |
| Sep 30, 2024 | 67.00 Mn |
| Sep 30, 2024 | 67.00 Mn |
| Jun 30, 2024 | 25.50 Mn |
| Jun 30, 2024 | 25.50 Mn |
| Mar 31, 2024 | 22.00 Mn |
| Mar 31, 2024 | 22.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Dec 31, 2023 | 3.00 Mn |